|Breast Cancer HER2||35||Ukraine||2017||currently in treatment|
Ganna, Breast Cancer HER2
|35||Ukraine||2017||currently in treatment|
In 2017 the patient was diagnosed with a Breast Cancer HER2, stage III.
Primary tumor in right breast with metastases in lymph nodes.
Biomarkers already tested:
– ER+PR+Her2/neu2+ Ki67 – 40%, BRCA1 mutation
– No treatment
– BRCA1 confirmation + TP53, CYP2D6, PIK3CA variants
– Her2/ERBB2 amplification
– IHC : ERBB2 + / CDK4/6
– Dual PI3K/mTOR inhibitors
– CDK4/6 inhibitors (clinical trials, as drug approved for other cancer types)
Patient just started treatment.